First-in-human administration of terbium-161-labelled somatostatin receptor subtype 2 antagonist ([161Tb]Tb-DOTA-LM3) in a patient with a metastatic neuroendocrine tumour of the ileum-Reference-Cited by-同舟云学术

First-in-human administration of terbium-161-labelled somatostatin receptor subtype 2 antagonist ([161Tb]Tb-DOTA-LM3) in a patient with a metastatic neuroendocrine tumour of the ileum

Published:2024-03-07 Issue:8 Volume:51 Page:2517-2519
ISSN:1619-7070
Container-title:European Journal of Nuclear Medicine and Molecular Imaging
language:en
Short-container-title:Eur J Nucl Med Mol Imaging

Author:

Fricke Julia,Westerbergh Frida,McDougall Lisa,Favaretto Chiara,Christ Emanuel,Nicolas Guillaume P.,Geistlich Susanne,Borgna Francesca,Fani Melpomeni,Bernhardt Peter,van der Meulen Nicholas P.,Müller Cristina,Schibli Roger,Wild Damian^ORCID

Funder

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung

University of Basel

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s00259-024-06641-w.pdf

Reference3 articles.

1. Marin I, Ryden T, Van Essen M, Svensson J, Gracheva N, Köster U, Zeevaart JR, van der Meulen NP, Müller C, Bernhardt P. Establishment of a clinical SPECT/CT protocol for imaging of 161Tb. EJNMMI Phys. 2020;7(1):45. https://doi.org/10.1186/s40658-020-00314-x.

2. Fani M, Mansi R, Nicolas GP, Wild D. Radiolabeled somatostatin analogs-a continuously evolving class of radiopharmaceuticals. Cancers (Basel). 2022;14(5):1172. https://doi.org/10.3390/cancers14051172.

3. Borgna F, Haller S, Rodriguez JMM, Ginj M, Grundler PV, Zeevaart JR, Köster U, Schibli R, van der Meulen NP, Müller C. Combination of terbium-161 with somatostatin receptor antagonists-a potential paradigm shift for the treatment of neuroendocrine neoplasms. Eur J Nucl Med Mol Imaging. 2022;49(4):1113-1126. https://doi.org/10.1007/s00259-021-05564-0.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of the tolerability of 161Tb- and 177Lu-labeled somatostatin analogues in the preclinical setting;European Journal of Nuclear Medicine and Molecular Imaging;2024-07-24

2. Comparison of the tolerability of¹⁶¹Tb- and¹⁷⁷Lu-labeled somatostatin analogues in the preclinical setting;2024-03-29